Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of Buprenorphine Sublingual Spray vs Standard of Care for Post-Operative Pain
NCT03254459Phase 2Completed
- Sponsor
- Insys Therapeutics
- Start
- Sep 2017
- Primary completion
- Nov 2017
- Modality
- Orthosteric Ligands, Inhalation Devices
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in postoperative pain comparing Buprenorphine Sublingual Spray with Standard of Care (2 arms). Primary endpoint: Number of Participants With Treatment Emergent Adverse Events. Started Sep 2017; status: completed.
02
Drugs
v1003
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03254459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03254459.